These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15596574)

  • 1. Microangiopathic hemolysis and renal failure in malignant hypertension.
    van den Born BJ; Honnebier UP; Koopmans RP; van Montfrans GA
    Hypertension; 2005 Feb; 45(2):246-51. PubMed ID: 15596574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Renal Outcome among Japanese Patients with or without Microangiopathic Hemolysis in Malignant Phase Hypertension: A Single-Center Retrospective Study.
    Nagayama Y; Inoue Y; Inui K; Yoshimura A
    Nephron; 2017; 137(3):197-204. PubMed ID: 28817823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.
    Roussos L; Christensson A; Thompson O
    Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension.
    Lip GY; Beevers M; Beevers DG
    J Hypertens; 2000 Jan; 18(1):97-101. PubMed ID: 10678549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic disparities in the incidence, presentation and complications of malignant hypertension.
    van den Born BJ; Koopmans RP; Groeneveld JO; van Montfrans GA
    J Hypertens; 2006 Nov; 24(11):2299-304. PubMed ID: 17053554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease.
    Marone LK; Clouse WD; Dorer DJ; Brewster DC; Lamuraglia GM; Watkins MT; Kwolek CJ; Cambria RP
    J Vasc Surg; 2004 Feb; 39(2):322-9. PubMed ID: 14743131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery in malignant hypertension presenting as acute renal failure.
    Isles CG; McLay A; Jones JM
    Q J Med; 1984; 53(212):439-52. PubMed ID: 6515000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study.
    Shantsila A; Lane DA; Beevers DG; Lip GY
    J Hypertens; 2012 May; 30(5):974-9. PubMed ID: 22495136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome for renal artery stenting performed for salvage of renal function.
    Modrall JG; Timaran CH; Rosero EB; Chung J; Arko FA; Valentine RJ; Clagett GP; Trimmer C
    J Vasc Surg; 2011 Nov; 54(5):1414-1421.e1; discussion 1420-1. PubMed ID: 21803522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-EVAR does not Impair Renal Function more than Open Surgery for Juxtarenal Aortic Aneurysms: Single Centre Results.
    Shahverdyan R; Majd MP; Thul R; Braun N; Gawenda M; Brunkwall J
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):432-41. PubMed ID: 26100450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short-term course of renal function in malignant hypertensives with renal insufficiency.
    Lawton WJ
    Clin Nephrol; 1982 Jun; 17(6):277-83. PubMed ID: 7105502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appraisal of renal failure reversing therapies in lupus nephritis].
    Yang X; Liang L; Zhan Z; Ye Y; Liu Y; Yu X; Chen W; Yin P
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):113-6. PubMed ID: 11798566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial recovery of renal function in black patients with apparent end-stage renal failure due to primary malignant hypertension.
    James SH; Meyers AM; Milne FJ; Reinach SG
    Nephron; 1995; 71(1):29-34. PubMed ID: 8538845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney.
    Davies MG; Saad WE; Bismuth JX; Naoum JJ; Peden EK; Lumsden AB
    J Vasc Surg; 2009 Apr; 49(4):953-60. PubMed ID: 19217744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible renal failure in malignant hypertension.
    Cordingley FT; Jones NF; Wing AJ; Hilton PJ
    Clin Nephrol; 1980 Aug; 14(2):98-103. PubMed ID: 7408261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular management of transplant renal artery stenosis.
    Touma J; Costanzo A; Boura B; Alomran F; Combes M
    J Vasc Surg; 2014 Apr; 59(4):1058-65. PubMed ID: 24365122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
    Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
    Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.